Efficacy and safety of decitabine combined with low-dose cytarabine, aclarubicin, and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation

• Si-Si Chen,
• Qian Sun,
• Lan Cao,
• Wen-Zhong Wu,
• Yue Xie,
• Chun Qiao,
• Jian-Yong Li,
• Si-Xuan Qian,
• Ming Hong,
• Peng Lyu.

Affiliations

Si-Si Chen

Qian Sun

Lan Cao

Wen-Zhong Wu

Yue Xie

Chun Qiao

Jian-Yong Li

Si-Xuan Qian

Ming Hong

Peng Lyu.